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0022-2836 © 2012 Elsevier Ltd. Open accThe glucocorticoid receptor (GR) is a member of the steroid receptor family
of ligand-activated transcription factors. A long-standing question has
focused on how GR and other receptors precisely control gene expression.
One difﬁculty in addressing this is that GR function is inﬂuenced by
multiple factors including ligand and coactivator levels, chromatin state,
and allosteric coupling. Moreover, the receptor recognizes an array of DNA
sequences that generate a range of transcriptional activities. Such
complexity suggests that any single parameter—DNA binding afﬁnity,
for example—is unlikely to be a dominant contributor to function. Indeed, a
number of studies have suggested that for GR and other receptors, binding
afﬁnity toward different DNA sequences is poorly correlated with
transcriptional activity. As a step toward determining the factors most
predictive of GR function, we rigorously examined the relationship between
in vitro GR-DNA binding energetics and in vivo transcriptional activity. We
ﬁrst demonstrate that previous approaches for assessing afﬁnity–function
relationships are problematic due to issues of data transformation and
linearization. Thus, the conclusion that binding energetics and transcrip-
tional activity are poorly correlated is premature. Using more appropriate
analyses, we ﬁnd that energetics and activity are in fact highly correlated.
Furthermore, this correlation can be quantitatively accounted for using
simple binding models. Finally, we show that the strong relationship
between energetics and transcriptional activity is recapitulated in multiple
promoter contexts, cell lines, and chromatin environments. Thus, despite
the complexity of GR function, DNA binding energetics are the primary
determinant of sequence-speciﬁc transcriptional activity.© 2012 Elsevier Ltd.Open access under CC BY-NC-ND license.t of Pharmaceutical Sciences, C-238, University of Colorado Anschutz Medical
levard, Aurora, CO 80045, USA. E-mail address: david.bain@ucdenver.edu.
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19Energetic Analysis of GR FunctionIntroduction
The glucocorticoid receptor (GR) is a member of
the steroid receptor family of ligand-activated
transcription factors.1 The receptor controls the
activity of large gene networks associated with a
variety of developmental and metabolic processes
and has long served as a model system for
understanding the mechanisms responsible for
higher eukaryotic gene regulation. Brieﬂy summa-
rized, the traditional understanding of GR function
is that upon binding ligand, the receptor di-
merizes, binds glucocorticoid response elements
(GREs) located within upstream promoter sites,
and recruits coactivating proteins to activate
transcription.
Although the above model provides a strong
qualitative framework for understanding GR func-
tion, it nonetheless remains incomplete. Speciﬁcal-
ly, we have yet to determine the quantitative
mechanisms by which GR and other steroid re-
ceptors control gene expression. One difﬁculty in
addressing this is that, in contrast to “simple” gene
regulatory proteins such as phage or bacterial
repressors, GR activity is inﬂuenced by numerous
factors. These include ligand and coactivator levels,
chromatin state, and allosteric linkages.1–4 Unfor-
tunately, the relative contribution of each factor to
GR activity is unknown, as is the extent to which
each is functionally and structurally coupled to
another. This lack of knowledge, critical for
modeling simple systems,5,6 makes it impossible
to develop a truly predictive understanding of GR
function.
Another complication is that GR, like other
steroid receptors, is capable of binding to a wide
variety of GREs.7 Typically, these are imperfect
palindromes that vary by one or more base pairs.
Why GR should require different sequences for
function is unclear. Studies of model systems
would suggest that the different sequences generate
differences in receptor binding afﬁnity, thus leading
to differences in transcriptional activation.6 How-
ever, for GR and other receptors, semiquantitative
studies have concluded that DNA binding afﬁnity
to such sequences is poorly correlated to transcrip-
tional activity.2,8,9 Such an interpretation has
accelerated investigations into other gene regulato-
ry mechanisms, leading to the recent ﬁnding that
individual DNA sequences act as allosteric effectors
of receptor function.2
In order to understand the functional behavior of
receptors such as GR, we seek to determine the
factors most relevant to transcriptional activity. As a
step toward this goal, we rigorously analyzed the
relationship between in vitro GR-DNA binding
energetics and in vivo transcriptional activation.
We ﬁrst show that approaches historically used to
demonstrate weak correlation between DNA bind-ing afﬁnity and steroid receptor function are
problematic. This is so due to issues of data
transformation and linearization. Using more ap-
propriate analyses, we ﬁnd that energetics and
activity are in fact highly correlated. We then show
that the molecular origins of such correlation can be
accounted for using simple binding models. Finally,
we demonstrate that the strong relationship be-
tween energetics and activity is recapitulated in
multiple promoter contexts, cell lines, and chroma-
tin environments. Thus, GR-DNA binding energet-
ics are the dominant force in sequence-speciﬁc
transcriptional activation. This suggests that factors
such as sequence-speciﬁc allostery are subtler in
their contributions and that thermodynamic ap-
proaches should account for other aspects of GR
function.Results
To quantitatively explore the relationship be-
tween DNA binding energetics and transcriptional
activation, we ﬁrst puriﬁed full-length, human GR
as shown in Fig. 1a. We then used analytical
ultracentrifugation to assess GR assembly state and
extent of structural homogeneity. Representative
sedimentation velocity scans collected at
50,000 rpm are shown in Fig. 1b, and the resultant
sedimentation coefﬁcient distribution is shown in
Fig. 1c. It is evident that the vast majority of
ligand-bound GR sediments as a single 4.1 s
species. This species has an estimated molecular
mass of 83.7 kDa, and thus likely corresponds to
the GR monomer (calculated molecular mass of
90.9 kDa). This was conﬁrmed using sedimentation
equilibrium (Fig. 1d). Global ﬁtting of three GR
concentrations equilibrated at three rotor speeds
resolved an average molecular mass of 91.5
±6 kDa, in statistical agreement with the calculated
value for the monomer. Importantly, the near
agreement between the sedimentation velocity
and equilibrium results suggests that the GR
monomer is structurally homogenous. This is
entirely consistent with our previous work on
GR13 and lends credence to the DNA binding
studies described below.
The energetics of GR binding to seven previously
characterized GREs2 were determined using quan-
titative footprint titration. Shown in Fig. 2a is a
representative titration of one such sequence (Pal).
Two models were used to ﬁt the data. The ﬁrst is the
Langmuir binding model, which resolves the ap-
parent binding afﬁnity (Kapp):
Y =
Kappx
1 + Kappx
ð1Þ
20 Energetic Analysis of GR Functionwhere Y is the fractional saturation at the GRE and x
is the total receptor concentration in monomer units.
The second model, schematically depicted in Fig. 2b,
allows us to resolve Ktot, the total afﬁnity forassembling two GR monomers at the palindromic
GRE:
Y =
Ktotx2
1 + Ktotx2
ð2Þ
where x is again the total GR concentration in
monomer units.
The experimental isotherm generated from the
footprint in Fig. 2a and best-ﬁt binding curve to the
Ktot model are shown in Fig. 2c. The total and
apparent binding afﬁnities for Pal and the remaining
GRE sequences are summarized in Table 1. (Fits to
both binding models for all GREs are shown in
Supplementary Fig. S1.) For the seven sequences, it
is evident that the true difference in GR binding
afﬁnities is not 60-fold as suggested by the Kapp
values but is instead nearly 700-fold. The primary
reason for this discrepancy is that the apparent
binding afﬁnity does not take into account the
dimeric stoichiometry of GR binding.14GR-DNA binding energetics are significantly
correlated to transcriptional activity
To assess the relationship between DNA binding
energetics and cellular function, we next measured
the ligand-dependent increase in transcriptional
activity (expressed as “fold-activation”) for each
GRE by transient transfection dose–response. Rep-
resentative results at an intermediate dose of GR
expression vector are shown in Table 1. Using the
traditional approach for assessing correlation,2,9 we
plotted apparent DNA binding afﬁnity versus fold
activation and carried out linear regression analysis
as shown in Fig. 3a. Consistent with previous
reports for GR and other receptors,2,8,9 there is
only a weak linear correlation between DNA
binding afﬁnity and transcriptional activity
(R2 =0.45). Thus, sequences with nearly identical
apparent afﬁnities (such as SGK and Cons) generate
statistically different functional activities, whereas
sequences with widely different afﬁnities (such as
GILZ and TAT4) generate identical activity. AsFig. 1. Puriﬁcation and quantitative characterization of
full-length, human GR. (a) Coomassie-stained SDS-PAGE
image of 5.8 μg puriﬁed GR. (b) Representative sedimen-
tation velocity scans collected at 50,000 rpm using 2.9μM
GR. (c) Sedﬁt c(s)10 analysis of 2.9 μM puriﬁed GR.
Sedimentation coefﬁcients were corrected to 20 °C and
water (s20,w) using standard approaches.
11 (d) Sedimen-
tation equilibrium analysis of 6.1, 2.4, and 0.8 μM GR
equilibrated at 15,000 rpm (ﬁlled squares), 18,000 rpm
(open circles), and 21,000 rpm (ﬁlled triangles). Lines
represent global ﬁt to single-species model using
NONLIN.12
Fig. 2. Quantitative analysis of GR-GRE binding
energetics. (a) Representative quantitative footprint titra-
tion image of GR binding to the Pal sequence. Schematic to
the right indicates position of the GRE and approximate
location of the transcriptional start site. (b) GR-GRE
assembly model depicting the total binding reaction and
macroscopic product constant (Ktot), the total afﬁnity for
assembling two GR monomers at a palindromic GRE. (c)
Fractional saturation (Y) of the Pal sequence from two
independent footprint titrations. Line represents global ﬁt
to both data sets using the Ktot binding model in (b) and
Eq. (2).
21Energetic Analysis of GR Functionsummarized in Table 2, this lack of correlation is
independent of GR expression dose.
The results in Fig. 3a appear to conﬁrm the
prevailing belief that DNA binding afﬁnity has littlebearing on transcriptional activity. However, this
conclusion is based on the assumption of a linear
relationship between the two parameters. We
therefore simulated the expected relationship if
DNA binding afﬁnity is the sole contributor to
function. Simulated dose–response curves were
generated using a modiﬁed version of Eq. (2) [see
Materials and Methods, Eq. (3)], the total binding
afﬁnities (Ktot) shown in Table 1, and an assumed
ﬁvefold maximal activation. The simulated dose–
response curves are shown in Fig. 3b. Transforma-
tion of six doses into a plot of apparent afﬁnity
versus fold-activation is shown in Fig. 3c. Regardless
of GR dose, the afﬁnity–activation relationship is
never linear as is typically assumed2,9 but is instead
highly nonlinear. In fact, the most extreme non-
linearity is found at the intermediate receptor doses
(e.g., 100 ng) most sensitive to changes in afﬁnity or
function. Nonlinearity is not a result of the model
used to generate the data but is a general conse-
quence of transforming any hyperbolic or sigmoi-
dal-shaped dose–response curve.
We next asked how experimental error inﬂuences
the observed relationship between afﬁnity and
function. We error-perturbed the data shown in
Fig. 3c and plotted the 100‐ng result in Fig. 3d. The
simulated data (comparable in appearance to the
experimental data in Fig. 3a) again show only weak
linear correlation between afﬁnity and function
(R2 =0.32). Moreover, as observed for the experi-
mental data, such lack of correlation is seen for most
GR expression doses (Table 2). (The increased
correlation seen at the higher doses is a consequence
of the undue inﬂuence of the weak TAT4 binding
afﬁnity.) Thus, data created using a model in which
afﬁnity is the sole contributor to function appear to
generate a result indicating no such contribution
exists. Of course, this occurs simply because a linear
correlation test was applied. One approach for
assessing correlation in this case is to linearize the
data via log-transformation and apply a Pearson's
test.15,16 Using this method, we ﬁnd that the
correlation for both the simulated and experimental
data in Fig. 3a and d is now statistically signiﬁcant
(P≤0.01; see Supplementary Fig. S2). Since the
simulations show that the predicted relationship
between afﬁnity and function is not only nonlinear
but also monotonic, we additionally carried out a
Spearman rank-order analysis.15 Again, we see
strong correlation (P≤0.05) for both the experimen-
tal and simulated data sets. Thus, contrary to
previous conclusions,2 GR binding afﬁnity is signif-
icantly correlated to transcriptional activity.
To determine the general utility of using log-
transformation or Spearman analyses to assess
afﬁnity–function relationships, we applied both
tests for GR expression doses ranging from 3 to
1500 ng. The results for the experimental and
simulated data are shown in Table 3. It is evident
Table 1. GRE sequences, apparent and total GR binding afﬁnities, and ligand‐induced fold-activation at 100 ng dose of
GR expression vector
GRE Sequence Kapp (nM)
a Ktot (fM
2)a Fold activationb
Pal AGAACAAAATGTTCT 32±7 0.800±0.134 2.4±0.19
CGT AGAACATTTTGTACG 34±5 0.877±0.123 2.3±0.23
SGK AGAACATTTTGTCCG 110±31 7.09±1.75 1.7±0.12
Cons AGAACAAAATGTACC 125±29 8.55±1.42 2.6±0.08
FKBP5 AGAACAGGGTGTTCT 356±73 64.9±7.80 1.6±0.12
GILZ AGAACATTGGGTTCC 490±125 105±16.4 1.2±0.14
TAT4 AGAACATCCCTGTACA 2,000±809 558±10.4 1.2±0.07
a Apparent (Kapp) and total (Ktot) GR-GRE binding afﬁnities±SD.
b Fold activation±SEM.
22 Energetic Analysis of GR Functionthat the ability to discern a statistically signiﬁcant
correlation between afﬁnity and function (Pb0.05) is
constrained within a small range of doses. For
example, the experimental data only reveal a
signiﬁcant correlation between 32 and 316 ng of
GR expression DNA by log-transform analysis and
between 32 and 100 ng by Spearman analysis. A
similar result is found using the simulated data. This
is exactly as predicted by an afﬁnity-based func-
tional model: Low GR plasmid doses (e.g., 3 ng)
generate no correlation simply because there is little
expression of GR protein and thus insufﬁcient
binding to the GREs to generate transcriptional
activity. Conversely, high doses (e.g., 1500 ng) show
little correlation because expression levels lead to
full occupancy, thus generating maximal transcrip-
tional activity for all GREs. Therefore, depending on
dose, even an appropriate statistical analysis (e.g.,
log-transform) will generate contradictory results.
Unfortunately, it is impossible to determine which
range of doses is most appropriate for any of the
above statistical analyses unless entire dose–re-
sponse curves for all DNA sequences of interest
are ﬁrst collected. More importantly, such an
approach ultimately focuses only on one dose
while ignoring the information content associated
with all others. Taken together, such linearization
approaches are therefore problematic for assessing
afﬁnity–function relationships. As described below,
a more powerful method is to instead directly ﬁt all
the data using molecular-based interaction models.
Energetics control sequence-specific
transcriptional activity
The results in Table 3 indicate that DNA binding
afﬁnity and transcriptional activation are signiﬁ-
cantly correlated. However, this result is based on
only a subset of the data and additionally offers no
molecular framework for describing such correla-
tion. To account for all the functional data rather
than just a subset, we globally ﬁt the dose–response
curves for the seven GREs using a simple binding
model. Shown in Fig. 4a are the experimental dose–response curves associated with each of the seven
GREs (ﬁlled circles). Also shown are rescaled dimer-
binding curves for the respective GREs (continuous
lines) as generated from the experimentally deter-
mined binding energetics and global ﬁt. For
comparative purposes, we also simulated error-
perturbed dose–response curves and processed
them using an identical approach (Fig. 4b).
By visual inspection, the DNA binding model
describes well almost all of the cellular data. This is
despite the fact that all GREs are assumed to
generate identical maximal and minimal fold activ-
ities and that the true range of DNA binding
afﬁnities for the seven GREs is nearly 700-fold.
Moreover, we note that the data are largely
indistinguishable from those in Fig. 4b, which
were simulated and ﬁt using a model that assumes
DNA binding afﬁnity is the sole contributor to
function. One obvious exception is the Pal sequence
(and perhaps the CGT sequence), which underesti-
mates the predicted fold activity. This result was
observed previously and ascribed to sequence-
speciﬁc allostery.2 However, noting the high quality
ﬁt for the remaining GREs, and the fact that Pal is a
palindrome not seen in the genome,7 we speculate
that the weaker than predicted activity is due to
high‐afﬁnity binding by both monomers, leading to
structural constraints and thus functional inhibition.
By contrast, the imperfect palindromes allow high‐
and low‐afﬁnity monomer binding likely to better
confer structural mobility and thus functional
activity.17
Affinity-based gene control is a general property
of GR function
The analyses in Fig. 4 suggest that a simple
binding model can account for sequence-speciﬁc
function. To determine whether these results were
unique to the seven GREs, we examined four
additional sequences—a GRE placed in reverse
orientation (TAT3,rev), two naturally occurring
GREs (MMTV and TAT3), and a synthetic, mutated
GRE (TAT3,mut). The ﬁtting results shown in Fig. 4a
Table 2. Regression of apparent afﬁnity versus fold
activation at eight expression vector doses for
experimental and simulated, error-perturbed data
Experimental Simulated
2 2
23Energetic Analysis of GR Functionwere used to predict the respective dose–response
curves, using the total afﬁnity (Ktot) determined for
the four GREs. As shown in Fig. 5, the predictions
capture the overall trends of all the functional data.
Thus, a simple model that assumes that DNADNA (ng) R DNA (ng) R
3 0.05 3 0.01
10 0.52 10 0.01
32 0.38 32 0.07
100 0.45 100 0.32
316 0.53 316 0.66
1000 0.24 1000 0.63
1259 0.31 1259 0.89
1500 0.28 1500 0.75binding energetics dictate sequence-speciﬁc tran-
scriptional output is sufﬁcient to describe the
functional behavior of nearly a dozen GREs.
Consistent with this, both log-transformation and
Spearman analyses of the 11 GRE sequences at the
100‐ng dose once again reveals statistically signiﬁ-
cant correlation (Pb0.02).
To determine whether our results were simply a
consequence of our experimental conditions, we
used the highest‐ and lowest‐afﬁnity GREs (Pal and
TAT4) to measure GR transcriptional activity in a
different promoter context, cell line, and chromatin
environment. Shown in Fig. 6a are the dose–
response curves for Pal and TAT4 carried out in
COS7 cells using a pA3 promoter (black; derived
from a minimal thymidine kinase promoter se-
quence). Overlaid are analogous measurements
generated using a pGL3 promoter (red; derived
from a minimal SV40 promoter sequence). We see
only subtle differences, suggesting that promoter
context has little inﬂuence on sequence-speciﬁc fold
activity. Shown in Fig. 6b are again the pA3 dose–
response curves for Pal and TAT4 in COS7 cells
(black); now overlaid are the analogous measure-
ments in U2OS cells (red). Although slight differ-
ences are observed for the Pal sequence, the trend of
Pal being a stronger activator than TAT4 isFig. 3. Kapp versus fold-activation for seven GREs. (a)
Plot of fold-activity values ±SEM for the seven GRE
sequences presented in Table 1; broken line represents
linear regression. An identical R2 result is obtained if the
data are plotted as a function of total binding afﬁnity
(Ktot). (b) Plot of simulated fold activity for the seven GREs
as a function of ng GR expression vector. Data points and
broken lines represent cross-sectional analysis used to
generate the plot in panel (c). (c) Plot of simulated fold
activities as a function of Kapp for six GR expression vector
doses (3, 32, 100, 316, 1000, and 1500 ng). (d) Plot of
simulated, error-perturbed fold activities ±SEM (n=3) for
the seven GRE sequences at the 100‐ng GR expression
vector dose; the broken line represents linear regression.
Error added was identical with that in (a) (see Materials
and Methods).
Table 3. Correlation analysis of Kapp and fold-activation for seven GRE sequences
Log-transform (Pearson's) Rank-order (Spearman's)
Experimentala Simulatedb Experimentala Simulatedb
DNA (ng) R2 P R2 P rs P rs P
3 0.01 0.80 0.14 0.40 0 1 −0.39 0.38
10 0.34 0.17 0.12 0.44 −0.54 0.21 0.39 0.38
32 0.63 0.03 0.44 0.10 0.75 0.05 0.50 0.25
100 0.73 0.01 0.86 ≤0.01 0.75 0.05 0.86 0.01
316 0.66 0.03 0.90 ≤0.01 0.68 0.09 0.96 ≤0.01
1000 0.31 0.19 0.37 0.14 0.50 0.25 0.43 0.34
1259 0.44 0.11 0.56 0.05 0.50 0.25 0.54 0.21
1500 0.40 0.10 0.61 0.04 0.64 0.12 0.54 0.21
R2, coefﬁcient of determination; rs, Spearman's rank correlation coefﬁcient; P, probability that the calculated correlation coefﬁcient (either
square root of R2 or rs) results from two uncorrelated variables.
a Analysis of the seven experimental GRE data sets in Fig. 4a.
b Analysis of the seven simulated, error-perturbed GRE data sets in Fig. 4b.
24 Energetic Analysis of GR Functionmaintained. Finally, in Fig. 6c, we tested the
inﬂuence of chromatin by stably transfecting three
GRE constructs into COS7 cells. Transcriptional
activity was then compared to that measured by
transient transfection; we see excellent correlation
(R2=0.99) between the transient and stable trans-
fection studies. Collectively, the results suggest that
afﬁnity-based gene control is a general feature of GR
function.Discussion
DNA binding energetics are the dominant
contributor to sequence-specific GR function
As noted in the Introduction, a number of factors
contribute to GR-mediated transcriptional activity.
However, the extent to which each contributes has
remained largely unknown. Such ignorance results
in an imprecise and possibly misleading image as to
how receptors function and makes it impossible to
develop meaningful quantitative models of recep-
tor-mediated gene regulation.
Here, we demonstrate that DNA binding energet-
ics are the dominant contributor to sequence-speciﬁc
transcriptional activity. This result has a number of
implications, the ﬁrst of which is that GR‐mediated
gene regulation is primarily under thermodynamic
control. That is, the kinetics of GR–promoter in-
teractions must be on a time scale considerably
faster than the kinetics of subsequent macromolec-
ular interaction events. This suggests that equilibri-
um-binding mechanisms may account for other
aspects of receptor function. However, it also
highlights the importance of kinetic studies for
understanding the time-dependent behavior of
receptor function.
Second, our results raise the question of how
receptors control the amplitude of transcriptionalactivity—the maximal fold-activation. Current
thinking suggests that receptor binding to DNA
response elements is coupled to structural changes
in other domains of the protein, thus generating an
allosteric signal for recruitment of coregulatory
molecules.1,2,18 We note that GR binding generates
a similar amplitude of activity regardless of
sequence (an average of approximately ﬁvefold;
see Fig. 4). We therefore suggest that the energetics
of allosteric coupling between receptor–DNA in-
teractions and receptor–coactivator recruitment
must be largely independent of DNA sequence.
More precisely, the difference in receptor–DNA
binding free energy in the absence and presence of
saturating amounts of coactivator (ΔΔG), which
deﬁnes the energetics of coactivator recruitment,19
should be constant as a function of GRE sequence. If
this were not the case, the maximal transcriptional
activation values we observe should differ dramat-
ically among GRE sequences, and DNA binding
afﬁnity alone should poorly describe our cellular
data.
Implications for other approaches used to
investigate the role of DNA sequence in
receptor function
We note that results presented here are at odds
with previous reports indicating a lesser role for
receptor–DNA binding afﬁnity and an enhanced
role for other mechanisms such as sequence-speciﬁc
allostery.2,9 However, these studies did not explic-
itly take into account the nonlinear relationship
between DNA binding afﬁnity and transcriptional
activity. Noting this, we examined more closely
other assays indicating an increased role for
individual DNA sequences in receptor function.
For the seven GREs in Table 1, we simulated dose–
response data in which GR binding afﬁnity (Ktot)
was reduced by 10-fold for all sequences (Fig. 7;
red). This might occur due to a mutation introduced
Fig. 4. Global ﬁtting of dose–
response curves indicates that
DNA binding energetics account
for sequence-speciﬁc transcription-
al activation. (a) Plots of dose–
response curves for seven GREs as
a function of GR expression vector
dose. Filled circles indicate fold-
activation ±SEM (n=3). Lines rep-
resent global ﬁt of all dose–re-
sponse curves using a simple
dimer-binding model, Ktot, for
each respective GRE, and global
scaling factors. (b) Same as (a) using
simulated, error-perturbed fold-ac-
tivation values. Error was identical
with that in (a).
25Energetic Analysis of GR Function
(a)
GRE Sequence Ktot (fM
2
) 
TAT3,rev TGTACAGGATGTTCT 4.35 ± 0.535 
MMTV AGAACAGTTTGTAAC 20.00 ± 2.87 
TAT3 AGAACATCCTGTACA 32.36 ± 0.362
TAT3,mut AGAACATCCTGTAAA 61.35 ± 10.20
(b)
Fig. 5. Predicted and experimen-
tally determined dose–response
curves for four additional GREs.
(a) DNA sequence and experi-
mentally determined GR binding
afﬁnity for the four GREs. (b)
Dose–response curves ± SEM
(n=3) for GR-induced activity
for the four GREs. Broken lines
represent predicted dose–response
curves using respective Ktot
shown in (a) and scaling factors
resolved in Fig. 4.
26 Energetic Analysis of GR Functioneither into the receptor or in the DNA. We also
simulated data in which the maximal fold activity
associated with all GREs was reduced twofold
(yellow), as might occur in a coactivator-knockdown
experiment. For two GR expression doses (100 and
1000 ng), the resultant fold activities are shown
normalized to wild type (gray).
Even though the simulated changes in afﬁnity or
function were applied uniformly, the data at 100 ng
indicate that only a subset of sequences is affected.
Similar observations have been seen experimentally2
and have been interpreted to mean that DNA
sequences selectively inﬂuence GR function, al-
though this is not occurring here. Interestingly, a
different subset of sequences is affected at 1000 ng,
but only by the change in binding afﬁnity—the
change in fold activity by simulated coactivator
knockdown is now similar for all sequences. Thus,
different doses of GR expression vector generate
variable results, none of which arise from sequence-
speciﬁc effects. Rather, this occurs due to the
nonlinear relationship between afﬁnity and function:
Low doses of GR expression vector preferentially
reveal functional changes for high‐afﬁnity binding
sites, and vice versa. The simulations therefore
suggest that functional studies carried out as
shown in Fig. 7, similar to those in Fig. 3, areunreliable for assessing the role of DNA sequence in
steroid receptor function.
We emphasize that the results from these simula-
tions apply to more than just analyses of different
binding sequences. Receptor assembly at complex
promoters containing multiple binding sites will
also generate hyperbolic or sigmoidal dose–re-
sponse curves if under thermodynamic control. As
a consequence, mutagenic analysis of individual
binding sites within a complex promoter will
generate functional results similar to those seen in
Fig. 7. Therefore, studies indicating that different
response element sequences within a promoter
selectively inﬂuence transcriptional activity should
be viewed cautiously.
GR function is influenced by nucleotides other
than the conserved binding sites
The simulations in Fig. 7 suggest that approaches
previously used to assess the relationship between
binding afﬁnity and function may erroneously
amplify the contributions of other mechanisms
(e.g., sequence-speciﬁc allostery). However, one
GR binding sequence examined here (TAT4) has
been previously found to exhibit exceptionally
strong transcriptional activity despite having weak
Fig. 6. Sequence-speciﬁc activa-
tion is maintained in multiple pro-
moter types and cell lines, and in
chromatin environment. (a) pA3-
Pal and pA3-TAT4 dose–response
curves inCOS7 cells (black) overlaid
with dose–response curves ±SEM
(n=3) from the respective sequences
in pGL3 vector (red). (b) pA3‐Pal
and pA3-TAT4 dose–response
curves in COS7 cells (black) over-
laid with dose–response curves
±SEM (n=3) for respective se-
quences in U2OS cells (red). (c)
TA‐induced activity ±SEM (n≥2)
of pGL3-TAT4 (green), pGL3-Pal
(blue), and pGL3-TAT4-Y (red) de-
termined in transient and stably
transfected COS7 cells (1 μg GR
expression vector). The broken line
represents linear regression.
27Energetic Analysis of GR Functionbinding afﬁnity.2 Noting that this sequence did not
show strong activity in our studies (Figs. 4a and 6c),
we examined the role of the nucleotides immediate-
ly adjacent to the response element. Shown in Fig. 8a
are the sequences for a TAT4 variant used here
(pGL3-TAT4) and in Ref. 2 (pGL3-TAT4-Y or “Tat”;
donated by Dr. Keith Yamamoto). It is evident that
the only difference between the two constructs is the
presence of ﬁve nucleotides immediately 5′ and 3′ of
the TAT4 binding site. As shown in Fig. 8b, the TAT4
construct used in this study (green) generates only
weak activity. By contrast, the pGL3-TAT4-Y con-
struct (red) generates exceptionally strong activity.
Yet others and we ﬁnd no difference in GR binding
afﬁnity to TAT4 and TAT4-Y (Table 1 and Ref. 2).
Deletion or insertion of the ﬁve nucleotide
“spacer” 5′ to either TAT4 sequence had no affect
on function (data not shown). However, as seen in
Fig. 8b, 3′ addition of the ﬁve nucleotides to the
TAT4-Y sequence [blue; pGL3-TAT4-Y,(+)sp] signiﬁ-cantly reduces TAT4 activity, making it now
comparable to the variant used in the current
study. Likewise, 3′ deletion of these nucleotides in
the TAT4 construct used herein [black; pGL3-
TAT4,(−)sp] signiﬁcantly increases transcriptional
activity. Intriguingly, as shown in Fig. 8c, the effect
of these nucleotides appears to be unique to TAT4
since addition or deletion of this sequence to the Pal
construct generated no change in activity. We
speculate that the inﬂuence of the 3′ ﬂanking
sequence is somehow related to differences in GR
assembly at TAT4, which uniquely uses four rather
than three nucleotides to separate each half-site
(Table 1). Indeed, our footprinting studies of this
sequence reveal a distinctly different type of
protection pattern, suggestive of receptor-induced
structural changes to the DNA. Regardless, the data
in Fig. 8 suggest that the strong activity previously
reported for TAT4 may arise from effects other than
sequence-speciﬁc allostery.
Fig. 7. Relative fold activities for seven GREs as a
function of simulated mutagenesis and coactivator knock-
down. Simulated activity differences relative to wild type
(gray) for 100‐ng (top) and 1000‐ng (bottom) GR expres-
sion vector doses, when Ktot is reduced 10-fold (red) or
fold activity (FA) is reduced 2-fold (yellow) (*Pb0.05;
**Pb0.005).
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Our results demonstrate that GR-DNA binding
energetics are the major contributor to sequence-
speciﬁc gene regulation. By implication, other
regulatory mechanisms are minor. Since an ener-
getics-based framework can largely account for
differences in GRE-speciﬁc function, thermodynam-
ic approaches should be capable of predicting other
aspects of GR functional behavior. A major
initiative will be to develop a quantitative under-
standing of the coupling between receptor–DNA
interaction energetics, coactivator recruitment, and
amplitude of transcriptional activation (e.g., fold
activation). Studies moving in this direction are
already underway.20 Finally, since steroid receptors
comprise a family of homologous transcription
factors, we propose that energetics-based gene
control is common to the entire family. Noting
also that the receptors bind identical or nearly
identical DNA sequences, it should therefore be
possible to determine the quantitative mechanisms
responsible for steroid receptor-speciﬁc gene
regulation.Materials and Methods
Expression and purification of full-length, human GR
A baculovirus expression vector encoding human GR
(amino acids 1–777) fused to an N-terminal hexahistidine
tag was generated in‐house, using an expression plasmid
donated by Dr. Ronald Evans. The construct was
expressed in baculovirus-infected Sf9 cells. Cells were
treated with 1 μM triamcinolone acetonide (TA) 24 h
post-infection and harvested 24 h later. Puriﬁcation was
carried out as previously described13 and is only brieﬂy
summarized here. All puriﬁcation steps were carried out
at 4 °C and in the presence of 10 μM TA. Cells containing
GR were Dounce homogenized in a low-salt lysis buffer.
The nuclear-localized fraction of GR was pelleted, and
GR was released from the nuclei by resuspension in an
extraction buffer. Following centrifugation, GR was
puriﬁed from the supernatant using Ni–NTA agarose
resin (Qiagen). The resin was extensively washed with
extraction buffer, and GR was eluted with the same
buffer now containing 250 mM imidazole. The receptor
was then chromatographed using a Sephacryl S-300 HR
size‐exclusion column (GE Life Sciences). The fractionat-
ed receptor was concentrated using Q-Sepharose (Amer-
sham Biosciences). After elution with 500 mM NaCl, GR
was ﬂash-frozen and stored in liquid nitrogen. GR was
judged to be at least 95% pure by quantiﬁcation of
Coomassie Blue‐stained SDS‐PAGE. GR concentration
was determined using an extinction coefﬁcient of
71,280 M− 1 cm− 1.21 Mass spectrometry analysis of tryp-
sin-digested receptor resolved fragment masses with the
highest probability of corresponding to residues 5–777.
The presence of the N‐terminal His-tag was conﬁrmed by
immunoblotting.Analytical ultracentrifugation
All sedimentation studies were carried out on a Beck-
man XL-A analytical ultracentrifuge as previously
described.22,23 Studies were carried out in a buffer
containing 20 mM Hepes or Tris (pH 8.0 at 4 °C), 50 mM
NaCl, 0.5 mM DTT, 1 mM CaCl2, 2.5 mM MgCl2, and
10 M TA. For sedimentation velocity, a single GR
concentration (2.9 μM) was sedimented at 4 °C using a
rotor speed of 50,000 rpm. Data was collected at 230 nm.
Sedimentation coefﬁcient c(s) distributions were deter-
mined using the program Sedﬁt.10 Sedimentation equilib-
rium experiments were carried out under identical
conditions, using three GR concentrations (6.1, 2.4, and
0.8 M) and three rotor speeds (15,000, 18,000, and
21,000 rpm). Data were analyzed individually and glob-
ally using nonlinear least-squares parameter estimation as
implemented in the program NONLIN12 to determine GR
assembly state.
Quantitative footprint titrations
Quantitative DNase footprint titrations were carried out
as originally described by Brenowitz et al.24 with slight
modiﬁcations.25 Reactions were carried out in an assay
buffer identical with that used in the sedimentation
(a)
Flanking mutants Sequence 
pGL3-TAT4 GGTAC CGTAC AGAACATCCCTGTACA CTGAC TCGAG 
pGL3-TAT4-Y GGTAC ---------- AGAACATCCCTGTACA ---------- TCGAG 
pGL3-TAT4-Y,(+)sp GGTAC ---------- AGAACATCCCTGTACA CTGAC TCGAG 
pGL3-TAT4,(-)sp GGTAC CGTAC AGAACATCCCTGTACA ---------- TCGAG 
Flanking mutants Fold-activation
pGL3-Pal
 
3.4 ± 0.3 
pGL3-Pal(-)sp 2.8 ± 0.3 
(b)
(c)
Fig. 8. Flanking sequence inﬂu-
ences transcriptional activity of the
TAT4 sequence in U2OS cells. (a)
TAT4 GRE in context of four
ﬂanking sequences within the
pGL3 vector. pGL3‐TAT4—se-
quence used in activation studies
presented in Fig. 4; pGL3‐TAT4-Y—
sequence identical with “Tat” used
in Ref. 2 (donated by Dr. Keith
Yamamoto) lacks a ﬁve‐base‐pair
“spacer” ﬂanking the GRE; pGL3‐
TAT4-Y,(+)sp—mutation of pGL3‐
TAT4-Y where the spacer is inserted
3′ of the GRE; pGL3‐TAT4,(−)sp—
mutation of pGL3‐TAT4 where the
3′ spacer is deleted. (b) Vectors
containing the TAT4 GRE sequence
(red, pGL3-TAT4-Y; green, pGL3-
TAT4) show a dramatic difference
in maximal fold-activation (left
panel). However, activation by the
pGL3-TAT4-Y vector is reduced
when the 3′ spacer is inserted
[blue, pGL3-TAT4-Y,(+)sp]. Likewise,
transcriptional activity of the
pGL3-TAT4 vector is increased
when the spacer is removed
[black, pGL3-TAT4,(−)sp] (right
panel). (c) Pal activities are statistically identical regardless of the presence of the downstream spacer. Fold activities
±SEM (n=3) of pGL3-Pal and pGL3-Pal lacking the 3′ spacer as tested in U2OS cells (1 μg GR expression vector).
29Energetic Analysis of GR Functionstudies, now containing 100 μg/ml bovine serum albumin
and 2 μg/ml salmon sperm DNA. Individual-site binding
isotherms were calculated as described previously25 using
ImageQuant (Molecular Dynamics).Resolution of DNA binding affinities
All GR binding isotherms were ﬁrst analyzed using the
Langmuir binding isotherm [Eq. (1)] to determine appar-
ent binding afﬁnity, Kapp. This value is “apparent”
because it does not account for the stoichiometry of two
monomers binding to the palindromic sequence. To
facilitate comparison to other reports, the association
constants determined here are reported in the main text as
the inverse or dissociation constants.
Independent ﬁtting of the GR data to the Hill
equation yielded a Hill coefﬁcient statistically identical
to 2 for all GREs. (These ﬁts were visually indistin-
guishable from those shown in Supplementary Fig. S1a.)
Thus, GR binding to the palindrome is highly
cooperative,26 and the singly ligated monomer GR-
DNA species is not signiﬁcantly populated at equilibri-
um. Thus, the isotherms were next ﬁt to a contracted
Adair equation to resolve Ktot—the total afﬁnity for two
GR monomers to fully ligate a palindromic response
element, regardless of pathway [Eq. (2)]. Finally, all
isotherms were analyzed using the program Scientist
(Micromath, Inc.).Plasmid construction for cellular assays
Eleven GREs, seven of which had been previously
characterized,2 were generated in a pA3-Luc plasmid27,28
by site-directed mutagenesis. A single GRE, correspond-
ing to a sequence derived from the palindromic tyrosine
amino transferase promoter (TAT3; AGAACATCCTG-
TACA), was successively mutated to generate a total of 11
GREs. All sequences, unless otherwise noted, were in the
orientation 5′-CTAGG GGATC AGAACATCCTGTACA
GGATC CAGTC-3′. Two additional sequences, Pal and
TAT4, were cloned into the KpnI and XhoI sites of a pGL3-
promoter plasmid (Promega). The orientation was iden-
tical with that of the pA3 vectors; however, the ﬂanking
sequences were now 5′-CGTAC AGAACATCCTGTACA
CTGAC-3′. Finally, full-length, human GR was cloned
into a pcDNA 3.1 mammalian expression vector, both as a
hexahistidine-tagged and untagged construct. No differ-
ences in transcriptional activation properties were ob-
served between the two constructs.
Transient transfections
Transfections were carried out in six-well plates. Cells
were seeded at a density of 2×105 cells/well. Twenty-four
hours later, the cells were transfected by adding 1000 ng/
well of the respective reporter construct (e.g., pA3-Pal-
Luc) and either 3.2, 10, 32, 100, 316, 1000, 1258, or 1500 ng/
30 Energetic Analysis of GR Functionwell pcDNA 3.1 containing the GR expression vector. The
total DNA amount was kept constant at 2500 ng/well
using empty pcDNA 3.1. DNA complexes were prepared
using TransIT-LT1 transfection reagent (Mirus Bio). After
24 h, the medium was replaced with one containing either
ethanol control or 10 nM TA; each condition was assayed
in triplicate. Luciferase assays were performed 24 h after
hormone treatment.
Luciferase assays
Cell monolayers from each six-well plate were rinsed
with cold phosphate‐buffered saline. Cells were lysed by
the addition of 0.5 ml of lysis buffer, and each lysate was
centrifuged to pellet cell debris. Luciferase assays were
performed on the supernatants as described previously.29
Protein concentrations were determined by bicinchoninic
acid assay (Pierce). Ethanol and TA-induced luciferase
activities were normalized to milligrams of extract protein
and reported as relative light units (RLU) per milligram.
The activities from each condition were averaged and the
error associated with each average was reported as
±standard error of the mean (SEM) (see Supplementary
Fig. S3). This error was subsequently used to determine
the extent of intra-experimental error (described below).
The transfection studies were carried out two more times,
the resultant values were averaged, and the error was
again reported as ±SEM. This latter value was used to
determine the extent of inter-experimental error (see
below). Finally, ligand-dependent activity (fold-activation
as shown in, for example, Fig. 4) was calculated by
dividing average TA-treated activity by average ethanol
activity. GR-induced activities were identical in TA and
dexamethasone, another typically used GR agonist (data
not shown).
To determine the relationship between amount of
transfected expression plasmid and intracellular protein
expression, we used immunoblot analysis. Whole‐cell
lysates from cells transfected as a function of GR
expression dose were probed with the GR-speciﬁc
antibody E20 (Santa Cruz Biotechnology) and an anti-β-
actin antibody (Sigma). Band densities were determined
using ImageQuant (Molecular Dynamics). Relative ex-
pression for GR was calculated from the intensity ratio of
GR to β-actin (see Supplementary Fig. S4).
Stable transfections
The plasmids pGL3-TAT4, pGL3-Pal, and pGL3-TAT4-Y
(“Tat” in Ref. 2; donated by Dr. Keith Yamamoto) were
stably transfected into COS7 cells. A total of 1×106 COS7
cells/10-cm dish were plated and allowed to grow for 24 h
before transfection. DNA complexes were prepared as
described for transient transfection. The complexes con-
taining a total of 10.5 μg/0.1 ml DNA (10 μg test plasmid
plus 0.5 μg pLKO.1-puro) were added to culture dishes
containing 3 ml of growth medium. After 24 h, the
medium was removed and replaced with medium
containing 1 μg/ml puromycin. After selection in puro-
mycin-containing medium, the cells were expanded,
pooled, and analyzed by PCR to conﬁrm plasmid
integration. Pooled cells were transiently transfectedwith 1 μg GR expression plasmid to test for functional
activity via luciferase assay.
Global fitting and simulation of dose–response curves
To determine whether sequence-speciﬁc transcriptional
activity can be quantitatively described by GR binding
energetics, we globally ﬁt dose–response curves generated
from seven GREs to a modiﬁed version of Eq. (2):
foldactivationð Þi = d−eð Þ
f ⋅Ktot;ix2
1 + f ⋅Ktot;ix2
+ e ð3Þ
where the binding equation is identical, but the overall
expression is modiﬁed by scaling factors d, e, and f. These
three parameters allow the binding curves determined
from the footprinting data to be numerically ﬁt (and thus
rescaled) to their respective fold-activation curves. Thus,
the binding isotherms are treated as transition curves,
where d rescales the y-axis amplitude, e shifts the y-axis
baseline, and f converts the x-axis from GR concentration
in molar units to GR expression plasmid in nanogram
units. The binding constants for each GRE (i), Ktot,i, were
ﬁxed during the ﬁt whereas the scaling factors were
allowed to ﬂoat. Since d, e, and f are global parameters
common to all data sets, all binding curves were rescaled
identically.
The identical binding expression and resolved scaling
factors d, e, and f were used to simulate perfect and error-
perturbed dose–response curves. For perfect dose–re-
sponse curves, the scaling factors were ﬁxed at the values
resolved from ﬁtting the experimental data, Ktot was ﬁxed
at the value appropriate to the GRE in question, and data
were simulated over a range and spacing of GR expression
doses identical with those used experimentally. These
data were then transformed to generate Fig. 3c.
To simulate the error-perturbed data in Figs. 3d and 4b,
the experimental ligand-dependent activity plots for each
GRE (e.g., Supplementary Fig. S3) and associated dose–
response curves (Fig. 4a) were ﬁrst analyzed to determine
the proportion of intra- and inter-experimental error,
respectively. The proportion of intra-experimental error
for ethanol and TA-treated samples is deﬁned as the SEM
for each GR expression dose (j) multiplied by the number
of experiments (n) associated with that dose, divided by
the corresponding normalized RLU:
proportion of intra  exp errorð Þj =
SEMj × n
RLU=mg
 
j
ð4Þ
Inter-experimental error was deﬁned as the SEM for each
dose (j) multiplied by the number of experiments (n)
associated with that dose, divided by the corresponding
fold-activation:
proportion of inter  exp errorð Þj =
SEMj × n
foldactivationð Þj
ð5Þ
Although the extent of both types of error varied slightly
from GRE to another, these differences were undetectable
31Energetic Analysis of GR Functionin subsequent simulations. We therefore used averaged
intra- and inter-experimental errors to carry out the
simulations shown here.
For both types of error, the proportion was independent
of dose and consistent with a Gaussian distribution (see
Supplementary Fig. S5). We therefore used a random
number generator to add Gaussian‐distributed, constant
relative error. To generate error-perturbed data for the
ethanol control associated with each GRE, we added 9.8%
relative error to the averaged, experimental ethanol-
treated RLU value. For the TA-treated samples, we used
the perfect data generated earlier for each GRE, multiplied
by the averaged ethanol-treated RLU value, and added
11.0% relative error. For both ethanol and TA treatments,
this was carried out in triplicate, exactly as described for
our experimental data. The three data sets from each
condition were then averaged and the fold-activation
values were determined. This data set was used to
generate two subsequent error-perturbed data sets (also
as carried out experimentally), each now containing 13.2%
inter-experimental error. The ﬁnal three data sets were
averaged and globally ﬁt as described for the experimental
data in Fig. 4a. The results are reported in Fig. 4b. For the
simulations in Fig. 7, an identical approach was used,
except either GR binding afﬁnity or fold activity was
reduced as indicated.Acknowledgements
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